JANUS HENDERSON GROUP PLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1274173 LONDON, X0

Position in ARQT

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$43,693,574

-$9,451,397 QoQ

Shares Held

1,854,566

+1.3% QoQ

Ownership

1.48%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 97.56816419582802.ToString("F0")% None 2.4318358041719734.ToString("F0")%

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,891,382,798 across 182 Biotechnology names. ARQT ranks #62 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,541,732	$1,856,099,791
2	PRAX	Praxis Precision Medicines, Inc.	3,458,863	$1,114,411,067
3	MDGL	Madrigal Pharmaceuticals, Inc.	2,018,647	$1,056,701,142
4	BBIO	BridgeBio Pharma, Inc.	13,179,013	$978,673,503
5	PCVX	Vaxcyte, Inc.	16,575,875	$963,224,094
6	VRTX	Vertex Pharmaceuticals Inc / Ma	2,131,527	$951,812,064
7	RVMD	Revolution Medicines, Inc.	9,766,496	$949,791,733
8	MIRM	Mirum Pharmaceuticals, Inc.	6,945,813	$641,654,204

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$43,693,574	1,854,566	+1.3%	Shares	Defined	2026-05-18
2025-12-31	$53,144,971	1,830,061	-23.7%	Shares	Defined	2026-02-17
2025-09-30	$45,202,884	2,398,031	+5.9%	Shares	Defined	2025-11-14
2025-06-30	$31,740,719	2,263,960	+4204.1%	Shares	Defined	2025-08-14
2025-03-31	$822,664	52,600	0.0%	Shares	Defined	2025-05-15
2024-12-31	$732,718	52,600	0.0%	Shares	Defined	2025-02-14
2024-09-30	$489,180	52,600	0.0%	Shares	Defined	2024-11-14
2024-06-30	$489,180	52,600	+131.5%	Shares	Defined	2024-08-14
2023-09-30	$120,664	22,724	+0.0%	Shares	Defined	2023-11-14
2023-06-30	$216,473	22,715	-0.2%	Shares	Defined	2023-08-14
2023-03-31	$250,371	22,761	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.